Evaluation of the Action of MOBIDERM® on Periarticular Edema After Total Knee Prosthesis - Randomized Controlled

Evaluation of the Action of MOBIDERM® on Periarticular Edema After Total Knee Prosthesis - Randomized Controlled Pilot Study

We hypothesize that the use of MOBIDERM® after total knee prosthesis allows a greater and faster resorption of periarticular edema:

• improvement of knee flexion;
• faster functional gain;
• faster decrease in postoperative pain by decreasing tissue tension.

Inclusion Criteria:

• Patient requiring a first total knee prosthesis (scheduled between Tuesday and Friday).
• Patient that has given his/her free and informed consent and signed the consent form.
• The patient must be a member or beneficiary of a health insurance plan
• The patient is at least 18 years old (≥) and under 90 years old (<).

Exclusion Criteria:

• The subject is in a period of exclusion determined by a previous study (therapeutic study)
• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• The patient is pregnant or breastfeeding
• The patient is allergic to latex bandages.
• The subject has contralateral amputation, pressure ulcers, severe Obstructive Arteriopathy of Lower Limbs, lymphoedema or thromboembolic event of the lower limb (ipsilateral and / or contralateral / superficial or deep or detected by postoperative Doppler).
• The subject has chronic or active wounds or any cause that hinders normal rehabilitation or the application of a bandage.
• patient with a stroke / Disabling Neurological Pathology, Chronic Immunological Pathology / Systemic Disease.
• patient with Hepatic insufficiency.
• patient with Venous insufficiency (stages 3 and 4).
• The patient is on dialysis.
• The subject has cognitive or behavioral disorders (Parkinson's disease, cerebellar syndrome, opposition, agitation, dementia).
• The subject has a history of knee surgery.